Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
Top Cited Papers
- 1 October 2014
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 384 (9951), 1358-1365
- https://doi.org/10.1016/s0140-6736(14)61060-6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Global spread of dengue virus types: mapping the 70 year historyTrends in Microbiology, 2014
- Immunogenicity and Safety of a Recombinant Tetravalent Dengue Vaccine in Children and Adolescents Ages 9–16 Years in BrazilThe American Journal of Tropical Medicine and Hygiene, 2013
- Safety and immunogenicity of a tetravalent dengue vaccine in healthy children aged 2–11 years in Malaysia: A randomized, placebo-controlled, Phase III studyVaccine, 2013
- Revisiting Rayong: Shifting Seroprofiles of Dengue in Thailand and Their Implications for Transmission and ControlAmerican Journal of Epidemiology, 2013
- Safety and immunogenicity of three tetravalent dengue vaccine formulations in healthy adults in the USAVaccine, 2013
- Optimization and Validation of a Plaque Reduction Neutralization Test for the Detection of Neutralizing Antibodies to Four Serotypes of Dengue Virus Used in Support of Dengue Vaccine DevelopmentThe American Journal of Tropical Medicine and Hygiene, 2013
- Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trialThe Lancet, 2012
- Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2–45 yearsHuman Vaccines & Immunotherapeutics, 2012
- Immunogenicity and safety of tetravalent dengue vaccine in 2–11 year-olds previously vaccinated against yellow fever: Randomized, controlled, phase II study in Piura, PeruVaccine, 2012
- From research to phase III: Preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccineVaccine, 2011